BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24972003)

  • 1. Autoantibodies in pre-clinical autoimmune disease.
    Hu ZD; Deng AM
    Clin Chim Acta; 2014 Nov; 437():14-8. PubMed ID: 24972003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cryoglobulinemia in rheumatic diseases].
    Baranauskaĭte AA; Nasonov EL; Solov'ev SK
    Klin Med (Mosk); 1991 Jun; 69(6):23-32. PubMed ID: 1774903
    [No Abstract]   [Full Text] [Related]  

  • 5. Sensitivity and specificity for primary Sjögren's syndrome of IgA and IgG anti-alpha-fodrin antibodies detected by ELISA.
    Ruffatti A; Ostuni P; Grypiotis P; Botsios C; Tonello M; Grava C; Favaro M; Todesco S
    J Rheumatol; 2004 Mar; 31(3):504-7. PubMed ID: 14994395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for autoimmunity in humans.
    D'Cruz D
    Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
    Szántó A; Csípo I; Zeher M
    J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
    [No Abstract]   [Full Text] [Related]  

  • 8. Presymptomatic autoantibodies in Sjögren's syndrome: what significance do they hold for the clinic?
    Henriksson G
    Expert Rev Clin Immunol; 2014 Jul; 10(7):815-7. PubMed ID: 24867307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren's syndrome.
    Duda S; Witte T; Stangel M; Adams J; Schmidt RE; Baerlecken NT
    Immunol Res; 2017 Dec; 65(6):1099-1102. PubMed ID: 29138979
    [No Abstract]   [Full Text] [Related]  

  • 10. Sjögren's syndrome at the crossroad of polyautoimmunity.
    Amador-Patarroyo MJ; Arbelaez JG; Mantilla RD; Rodriguez-Rodriguez A; Cárdenas-Roldán J; Pineda-Tamayo R; Guarin MR; Kleine LL; Rojas-Villarraga A; Anaya JM
    J Autoimmun; 2012 Sep; 39(3):199-205. PubMed ID: 22749530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases in China.
    Li R; Sun X; Liu X; Yang Y; Li Z
    Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
    Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
    Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autoimmune diseases.
    Condemi JJ
    JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
    [No Abstract]   [Full Text] [Related]  

  • 15. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
    Ramos-Casals M; Brito-Zerón P; Font J
    Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
    Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
    Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?
    Cinoku I; Mavragani CP; Tellis CC; Nezos A; Tselepis AD; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):61-67. PubMed ID: 30156537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J; Fang W; Li ZG
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.